Amendment: Marketing authorisations for human medicinal products

This procedure concerns updates to the rules for examining changes to existing marketing authorisations for medicines. It aims to ensure that any variations to these authorisations are assessed appropriately, maintaining the safety and efficacy of medicinal products available to the public.

Pharmaceutical companies will be affected by these updated examination procedures when seeking to modify their authorised medicines. This ensures that changes to medicines are properly scrutinised before they are implemented on the market.